Tenet Healthcare Corporation $THC Shares Acquired by Truist Financial Corp

Truist Financial Corp increased its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 22.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 14,270 shares of the company’s stock after purchasing an additional 2,601 shares during the quarter. Truist Financial Corp’s holdings in Tenet Healthcare were worth $2,836,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of THC. Triumph Capital Management acquired a new position in Tenet Healthcare during the third quarter worth $25,000. Activest Wealth Management acquired a new position in Tenet Healthcare during the fourth quarter worth $26,000. William B. Walkup & Associates Inc. acquired a new position in Tenet Healthcare during the third quarter worth $32,000. Canada Pension Plan Investment Board acquired a new position in Tenet Healthcare during the second quarter worth $35,000. Finally, Westside Investment Management Inc. raised its holdings in Tenet Healthcare by 100.0% during the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after purchasing an additional 96 shares during the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 8,000 shares of the business’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $238.85, for a total transaction of $1,910,800.00. Following the completion of the sale, the executive vice president owned 12 shares of the company’s stock, valued at approximately $2,866.20. The trade was a 99.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Paola M. Arbour sold 6,500 shares of the business’s stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total value of $1,549,795.00. Following the sale, the executive vice president directly owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 46,517 shares of company stock valued at $10,943,111 over the last quarter. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare Price Performance

Shares of NYSE:THC opened at $195.90 on Wednesday. The company has a market cap of $16.87 billion, a P/E ratio of 10.19, a P/E/G ratio of 1.27 and a beta of 1.30. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a 52 week low of $146.60 and a 52 week high of $247.21. The business has a fifty day simple moving average of $202.05 and a 200-day simple moving average of $203.95.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Thursday, April 30th. The company reported $4.82 EPS for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. The business had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities research analysts forecast that Tenet Healthcare Corporation will post 17.56 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Guggenheim cut their price target on Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating for the company in a report on Friday, May 1st. TD Cowen reissued a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. KeyCorp cut their price target on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Barclays cut their price target on Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating for the company in a report on Tuesday, May 5th. Finally, Royal Bank Of Canada lowered their price objective on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research report on Friday, May 1st. Nineteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $244.16.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.